Biased Discordance of KRAS Mutation Detection in Archived Colorectal Cancer Specimens Between the ARMS-Scorpion Method and Direct Sequencing

被引:20
作者
Bando, Hideaki [1 ,2 ]
Tsuchihara, Katsuya [1 ]
Yoshino, Takayuki [2 ]
Kojima, Motohiro [3 ]
Ogasawara, Naomi [1 ]
Fukushima, Hiraku [2 ]
Ochiai, Atsushi [3 ]
Ohtsu, Atsushi [2 ]
Esumi, Hiroyasu [1 ]
机构
[1] Natl Canc Ctr Hosp E, Canc Physiol Project, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp E, Div Gastrointestinal Oncol, Kashiwa, Chiba 2778577, Japan
[3] Natl Canc Ctr Hosp E, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan
关键词
ARMS-Scorpion; colorectal cancer; direct sequencing; formalin-fixed paraffin-embedded specimen; KRAS; CETUXIMAB; CHEMOTHERAPY; SENSITIVITY;
D O I
10.1093/jjco/hyq216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The concordance of KRAS mutation detection between the amplification refractory mutation system-Scorpion assay and direct sequencing was evaluated with clinically available formalin-fixed, paraffin-embedded specimens of metastatic colorectal cancers. Genomic DNA from 120 macrodissected specimens was examined by the amplification refractory mutation system-Scorpion assay and direct sequencing. DNA mixtures of wild-type and mutant KRAS genes were prepared from the peripheral blood and the SW620 human colon cancer cell line for the model experiments. KRAS mutation was identified in 50 samples (41.7%) by the amplification refractory mutation system-Scorpion assay and 42 samples (35.0%) by direct sequencing. Discordance between the two methods was observed for samples with smaller amounts of amplifiable DNA. The sensitivity of direct sequencing was impaired by the decrease in template DNA and polymerase chain reaction cycles in the experimental models. Decreased sensitivity of direct sequencing caused by insufficient polymerase chain reaction amplification resulted in biased discordance between direct sequencing and amplification refractory mutation system-Scorpion. Polymerase chain reaction conditions satisfactory for amplifying tens of haploid copies of genomic DNA to the saturation level might be necessary to ensure the robustness of the direct sequencing-based method employed for formalin-fixed, paraffin-embedded specimen-derived DNA samples.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 15 条
[1]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[2]   A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations A Morphology-Based Approach in Colorectal Carcinoma [J].
Angulo, Barbara ;
Garcia-Garcia, Elena ;
Martinez, Rebeca ;
Suarez-Gauthier, Ana ;
Conde, Esther ;
Hidalgo, Manuel ;
Lopez-Rios, Fernando .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (03) :292-299
[3]   KRAS Mutation Comparison of Testing Methods and Tissue Sampling Techniques in Colon Cancer [J].
Franklin, Wilbur A. ;
Haney, Jerry ;
Sugita, Michio ;
Bemis, Lynne ;
Jimeno, Antonio ;
Messersmith, Wells A. .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (01) :43-50
[4]   KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection [J].
Jimeno, Antonio ;
Messersmith, Wells A. ;
Hirsch, Fred R. ;
Franklin, Wilbur A. ;
Eckhardt, S. Gail .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) :1130-1136
[5]   K-ras mutations and benefit from cetuximab in advanced colorectal cancer [J].
Karapetis, Christos S. ;
Khambata-Ford, Shirin ;
Jonker, Derek J. ;
O'Callaghan, Chris J. ;
Tu, Dongsheng ;
Tebbutt, Niall C. ;
Simes, R. John ;
Chalchal, Haji ;
Shapiro, Jeremy D. ;
Robitaille, Sonia ;
Price, Timothy J. ;
Shepherd, Lois ;
Au, Heather-Jane ;
Langer, Christiane ;
Moore, Malcolm J. ;
Zalcberg, John R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1757-1765
[6]   Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics [J].
Kotoula, Vassiliki ;
Charalambous, Elpida ;
Biesmans, Bart ;
Malousi, Andigoni ;
Vrettou, Eleni ;
Fountzilas, George ;
Karkavelas, George .
PLOS ONE, 2009, 4 (11)
[7]   ANALYSIS OF ANY POINT MUTATION IN DNA - THE AMPLIFICATION REFRACTORY MUTATION SYSTEM (ARMS) [J].
NEWTON, CR ;
GRAHAM, A ;
HEPTINSTALL, LE ;
POWELL, SJ ;
SUMMERS, C ;
KALSHEKER, N ;
SMITH, JC ;
MARKHAM, AF .
NUCLEIC ACIDS RESEARCH, 1989, 17 (07) :2503-2516
[8]   Feasibility and Robustness of Amplification Refractory Mutation System (ARMS)-based KRAS Testing Using Clinically Available Formalin-fixed, Paraffin-embedded Samples of Colorectal Cancers [J].
Ogasawara, Naomi ;
Bando, Hideaki ;
Kawamoto, Yasuyuki ;
Yoshino, Takayuki ;
Tsuchihara, Katsuya ;
Ohtsu, Atsushi ;
Esumi, Hiroyasu .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (01) :52-56
[9]   Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers [J].
Shigematsu, H ;
Lin, L ;
Takahashi, T ;
Nomura, M ;
Suzuki, M ;
Wistuba, II ;
Fong, KM ;
Lee, H ;
Toyooka, S ;
Shimizu, N ;
Fujisawa, T ;
Feng, ZD ;
Roth, JA ;
Herz, J ;
Minna, JD ;
Gazdar, AF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (05) :339-346
[10]   Effect of fixatives and tissue processing on the content and integrity of nucleic acids [J].
Srinivasan, M ;
Sedmak, D ;
Jewell, S .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (06) :1961-1971